Focus
Nuovi usi per vecchi farmaci nelle malattie autoimmuni
L. Lepore e coll.
Giugno 1999 - pagg. 368 -370
Parole chiave
Classificazione MeSH
Bibliografia
1. Mc Hugh SM, Rowland TL: Thalidomide
and derivatives: immunological investigations
of tumor necrosis factor-alfa (TNF-a) inhibition
suggest drugs capable of selective gene
regulation. Clin Exp Immunolol 110, 151,
1997.
2. Jacobson JM, Greenspan JS, Spritzler J, et al: Thalidomide for the treatment of oral aphthous ulcers in pazients with human immunodeficiency virus infection. N Engl J Med 336, 1487, 1997.
3. Hamuryudan V, Mat C, Saip S, et al: Thalidomide in the treatment of the mucocutaneous lesions of Behçet Syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128, 443, 1998.
4. Van Dullemen HM, Van Deventer JH, Hommes DW, et al: Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109, 129, 1995.
5. Odeka EB, Miller V: Thalidomide in oral Crohn’s disease refractory to conventional medical treatment. J Ped Gastroenterol Nutr 25, 250, 1997.
6. Wettstein AR, Meagher AP: Thalidomide in Crohn disease. Lancet 350, 1445, 1997.
7. Gutierrez-Rodriguez O, Starusta Bacal P, Gutierrez-Montes O: Treatment of refractory rheumatoid arthritis - the talidomide experience. J Rheumatol 16, 158, 1989.
8. Stambe C, Wicks IP: TNF-a and response of treatment-resistant adult-onset Still’s disease to thalidomide. Lancet 352, 544, 1998.
9. Wolkenstein P, Latarjet J, Roujeau JC, et al: Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352, 1586, 1998.
10. Parman T, Wiley MJ, Wells PG: Free radical- mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5, 582-5, 1999.
11. Powell RJ: New roles for thalidomide. BMJ 13, 377, 1996.
12. Present DH, Lichtiger S: Efficacy of Cyclosporine in treatment of fistula of Crohn’s disease. Digest Dis Science 39, 74, 1994.
13. Caccavo D, et al: Low dose cyclosporine modifies the course of systemic lupus erythematosus without kidney involvement. Arthr Rheum 40, 27, 1997.
14. Padeh S, Passwell JH: Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthr Rheum 41, 1210, 1998.
2. Jacobson JM, Greenspan JS, Spritzler J, et al: Thalidomide for the treatment of oral aphthous ulcers in pazients with human immunodeficiency virus infection. N Engl J Med 336, 1487, 1997.
3. Hamuryudan V, Mat C, Saip S, et al: Thalidomide in the treatment of the mucocutaneous lesions of Behçet Syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128, 443, 1998.
4. Van Dullemen HM, Van Deventer JH, Hommes DW, et al: Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109, 129, 1995.
5. Odeka EB, Miller V: Thalidomide in oral Crohn’s disease refractory to conventional medical treatment. J Ped Gastroenterol Nutr 25, 250, 1997.
6. Wettstein AR, Meagher AP: Thalidomide in Crohn disease. Lancet 350, 1445, 1997.
7. Gutierrez-Rodriguez O, Starusta Bacal P, Gutierrez-Montes O: Treatment of refractory rheumatoid arthritis - the talidomide experience. J Rheumatol 16, 158, 1989.
8. Stambe C, Wicks IP: TNF-a and response of treatment-resistant adult-onset Still’s disease to thalidomide. Lancet 352, 544, 1998.
9. Wolkenstein P, Latarjet J, Roujeau JC, et al: Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352, 1586, 1998.
10. Parman T, Wiley MJ, Wells PG: Free radical- mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5, 582-5, 1999.
11. Powell RJ: New roles for thalidomide. BMJ 13, 377, 1996.
12. Present DH, Lichtiger S: Efficacy of Cyclosporine in treatment of fistula of Crohn’s disease. Digest Dis Science 39, 74, 1994.
13. Caccavo D, et al: Low dose cyclosporine modifies the course of systemic lupus erythematosus without kidney involvement. Arthr Rheum 40, 27, 1997.
14. Padeh S, Passwell JH: Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthr Rheum 41, 1210, 1998.